Functional changes in somatostatin and neuropeptide Y containing neurons in the rat hippocampus in chronic models of limbic seizures

Epilepsy Research

Volumn 26, Issue 1, 1996, Pages 267-279

  Vezzani, A ^a   Schwarzer, C ^b   Lothman, E W ^c   Williamson, J ^c   Sperk, G ^b  

^a MARIO NEGRI INSTITUTE FOR PHARMACOLOGICAL RESEARCH   (Italy)

^b INNSBRUCK MEDICAL UNIVERSITY   (Austria)

^c UNIVERSITY OF VIRGINIA   (United States)

Author keywords

hippocampus; kindling; limbic system; mossy fibres; neurodegeneration; neuronal plasticity; seizures; sprouting; status epilepticus

Indexed keywords

NEUROPEPTIDE Y; SOMATOSTATIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; COMPLEX PARTIAL SEIZURE; CONFERENCE PAPER; CONTROLLED STUDY; EPILEPTIC STATE; HIPPOCAMPUS; MALE; NERVE CELL PLASTICITY; NONHUMAN; PRIORITY JOURNAL; RAT;

ANIMALS; DENTATE GYRUS; FUNCTIONAL LATERALITY; HIPPOCAMPUS; IMMUNOHISTOCHEMISTRY; KINDLING, NEUROLOGIC; LIMBIC SYSTEM; NERVE DEGENERATION; NEURONAL PLASTICITY; NEURONS; NEUROPEPTIDE Y; RATS; RNA, MESSENGER; SEIZURES; SOMATOSTATIN;

EID: 0030557498     PISSN: 09201211     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0920-1211(96)00059-9     Document Type: Conference Paper

References (57)

1. [1] Bakst, I., Avendano, C., Morrison, J.H. and Amaral, D.G., An experimental analysis of the origins of somatostatin-like immunoreactivity in the dentate gyrus of the rat, J. Neurosci., 6 (1986) 1452-1462.
2. [2] Bellmann, R., Widmann, R., Olenik, C., Meyer, D.K., Maas, D., Marksteiner, J. and Sperk G., Enhanced rate of expression and biosynthesis of neuropeptide Y after kainic acid induced seizures, J. Neurochem., 56 (1991) 525-530.
3. [3] Ben-Ari, Y., Limbic seizures and brain damage produced by kainic acid: Mechanisms and relevance to human temporal lobe epilepsy, Neuroscience, 14 (1985) 375-403.
4. [4] Bendotti, C., Vezzani, A., Tarizzo, G. and Samanin, R., Increased expression of GAP-43, somatostatin and neuropeptide Y mRNA in the hippocampus during development of hippocampal kindling in rats, Eur. J. Neurosci., 5 (1993) 1312-1320.
5. [5] Brooks, P.A., Kelly, J.S., Allen, J.M., Smith, D.A.S. and Stone, T.W., Direct excitatory effects of neuropeptide Y (NPY) on rat hippocampal neurons in vitro, Brain Res., 408 (1987) 295-298.
6. [6] Cavazos, J.E., Golarai, G. and Sutula, T.P., Mossy fibre synaptic reorganization induced by kindling: Time course of development, progression, and permanence, J. Neurosci., 11 (1991) 2795-2803.
7. 2 receptor, Br. J. Pharmacol., 102 (1991) 41-44.
8. [8] DeLanerolle, N.C., Kim, J.H., Robbins, R.J. and Spencer, D.D., Hippocampal interneuron loss and plasticity in human temporal lobe epilepsy, Brain Res., 495 (1989) 387-395.
9. [9] Deller, T. and Leranth, C., Synaptic connections of neuropepitide Y (NPY) immunoreactive neurons in the hilar area of the rat hippocampus, J. Comp. Neurol., 300 (1990) 433-447.
10. [10] Esclapez, M. and Houser, C.R., Somatostatin neurons are a subpopulation of GABA neurons in the rat dentate gyrus: Evidence from colocalization of pre-prosomatostatin and glutamate decarboxylase messenger RNAs, Neuroscience, 64 (1995) 339-355.
11. [11] Gall, C., Lauterborn, J., Isackson, P. and White, J., Seizures, neuropeptide regulation, and mRNA expression in the hippocampus, Prog. Brain Res., 83 (1990) 371-390.
12. [12] Goddard, G.V., McIntyre, D.C. and Leech, C.K., A permanent change in brain function resulting from daily electrical stimulation, Expl. Neurol., 25 (1969) 295-330.
13. 2 receptors in rat hippocampal slices in vitro, Br. J. Pharmacol, 113 (1994) 737-740.
14. [14] Gruber, B., Greber, S., Rupp, E. and Sperk, G., Differential NPY mRNA expression in granule cells and interneurons of the rat dentate gyrus after kainic acid, Hippocampus, 4 (1994) 1-9.
15. [15] Hashimoto, T. and Obata, K., Induction of somatostatin by kainic acid in pyramidal and granule cells of the rat hippocampus, Neurosci. Lett., 12 (1991) 514-527.
16. [16] Hökfelt, T., Johansson, O., Ljungdahl, A., Lundberg, J.M. and Schultzberg, M., Peptidergic neurones, Nature, 284 (1980) 515-521.
17. [17] Hökfelt, T., Neuropeptides in perspective: The last ten years, Neuron, 7 (1991) 867-879.
18. [18] Johansen, F.F., Tonder, N., Bruhn, T. and Diemer, N.H., Neuropeptide Y immunoreactivity is lost in rat hippocampus after cerebral ischemia and kainic acid seizures, Eur. J. Neurosci., Suppl. 2 (1989) 13.
19. [19] Köhler, C., Chan-Palay, V., Somatostatin-like immunoreactive neurons in the hippocampus: An immunocytochemical study in the rat, Neurosci. Lett., 34 (1982) 259-264.
20. [20] Köhler, C., Eriksson, L., Davies, S. and Chan-Palay, V., Neuropeptide Y innervation of the hippocampal region in the rat and monkey brain, J. Comp. Neurol., 244 (1986) 384-400.
21. [21] Köhler, C., Eriksson, L.G., Davies, S. and Chan-Palay, V., Co-localization of neuropeptide tyrosine and somatostatin immunoreactivity in neurons of individual subfields of the rat hippocampal region, Neurosci. Lett., 78 (1987) 1-6.
22. [22] Larhammar, D., Ericsson, A. and Persson, H., Structure and expression of the rat neuropeptide Y gene, Proc. Natl. Acad. Sci. USA, 84 (1987) 2068-2072.
23. [23] Leranth, C., Malcolm, A.J. and Frotscher, M., Afferent and efferent synaptic connections of somatostatin-immunoreactive neurons in the rat fascia dentata, J. Comp. Neurol., 295 (1990) 111-122.
24. [24] Leung, L.S., Spontaneous hippocampal interictal spikes following local kindling: Time course of changes and relation to behavioral seizures, Brain Res., 513 (1990) 308-314.
25. [25] Lothman, E.W., Bertram, III, E.H. and Stringer, J.L., Functional anatomy of hippocampal seizures, Prog. Neurobiol., 37 (1991) 1-81.
26. [26] Lothman, E.W. and Bertram, III, E.H., Epileptogenic effects of status epilepticus, Epilepsia, 34 (1993) S59-S70.
27. [27] Manfridi, A., Forloni, G.L., Vezzani, A., Fodritto, F., De Simoni, M.G., Functional and histological consequences of quinolinic and kainic acid-induced seizures on hippocampal somatostatin neurons, Neuroscience, 41 (1991) 127-135.
28. [28] Mazarati, A.M., and Teledgy, G., Effects of somatostatin and anti-somatostatin serum on picrotoxin-kindled seizures, Neuropharmacology, 31 (1992) 793-797.
29. [29] McNamara, J.O., Kindling: An animal model of complex partial epilepsy, Ann. Neurol., 16 (Suppl.) (1984) S72-S76.
30. [30] Milner, T.A., Bacon, C.E., Ultrastructural localization of somatostatin-like immunoreactivity in the rat dentate gyrus, J. comp. Neurol., 290 (1989) 544-560.
31. [31] Mitchell, J., Gatherer, M. and Sundstrom, L.E., Loss of hilar somatostatin neurons following tetanus toxin-induced seizures, Acta Neuropathol., 89 (1995) 425-430.
32. [32] Monnet, F.P., Fournier, A., Debonnel, G. and de Montigny, C., Neuropeptide Y potentiates response in the CA3 dorsal hippocampus. I. Involvement of an atypical neuropeptide Y receptor, J. Pharmacol. Exp. Ther., 263 (1992) 1212-1218.
33. [33] Monno, A., Rizzi, M., Samanin, R., and Vezzani, A., Antisomatostatin antibody enhances the rate of hippocampal kindling in rats, Brain Res., 602 (1993) 148-152.
34. 2 and differential changes in somatostatin receptor messenger RNAs, binding sites and somatostatin release in kainic acid-treated rats, Neuroscience, 65 (1995) 1087-1097.
35. [35] Pitkanen, A., Sirvio, J., Jolkkonen, J. and Riekkinen, P., Somatostatin-like immunoreactivity and somatostatin receptor binding in rat brain before and after pentylenetetrazole-induced convulsion, Neuropeptides, 7 (1986) 63-71.
36. [36] Racine, R.J., Modification of seizure activity by electrical stimulation. II. Motor seizure, Electroenceph. clin. Neurophysiol. 32 (1972) 281-294.
37. [37] Rizzi, M., Monno, A., Samanin, R., Sperk, G. and Vezzani, A., Electrical kindling of the hippocampus is associated with functional activation of neuropeptide Y-containing neurons, Eur. J. Neurosci., 5 (1993) 1534-1538.
38. [38] Robbins, R.J., Brines, M.L., Kim, J.H., Adrian, T., de-Lanerolle, N., Welsh, M.S. and Spencer, D.D., A selective loss of somatostatin in the hippocampus of patients with temporal lobe epilepsy, Ann. Neurol., 29 (1991) 325-332.
39. [39] Roder, C., Schwarzer, C., Vezzani, A., Gobbi, M., Mennini, T. and Sperk, G., Autoradiographic analysis of neuropeptide Y binding sites in the rat hippocampus after kainic acid-induced limbic seizures, Neuroscience, in press.
40. [40] Scharfman, H.E. and Schwartzkroin, P.A., Responses of cells of the rat fascia dentata to prolonged stimulation of the perforant path: Sensitivity of hilar cells and changes in granule cell excitability, Neuroscience, 35 (1990) 491-504.
41. [41] Scharfman, H.E., Presynaptic and postsynaptic actions of somatostatin in area CA1 and the dentate gyms of rat and rabbit hippocampal slices. In: T.V. Dunwiddie and D.M. Lovinger (Eds.), Presynaptic Receptors in the Mammalian Brain, Birkhauser, Boston, 1993, pp. 42-70.
42. [42] Schwarzer, C., Williamson, J.M., Lothman, E.W., Vezzani A. and Sperk, G., Somatostatin, neuropeptide Y, neurokinin B and cholecystokinin immunoreactivity in two chronic models of temporal lobe epilepsy, Neuroscience, 69 (1995) 831-845.
43. [43] Shinoda, H., Nadi, N.S., Schwartz, J.P., Alterations in somatostatin and proenkephalin mRNA in response to a single amygdaloid stimulation versus kindling, Mol. Brain Res., 11 (1991) 221-226.
44. [44] Sloviter, R.S., Decreased hippocampal inhibition and a selective loss of interneurons in experimental epilepsy, Science, 235 (1987) 73-76.
45. [45] Sloviter, R.S. and Nilaver, G., Immunocytochemical localization of GABA-cholecystokinin-, vasoactive intestinal polypeptide-, and somatostatin-like immunoreactivity in the area dentata and hippocampus of the rat, J. comp. Neurol., 256 (1987) 42-60.
46. [46] Sloviter, R.S. and Lowenstein, D.H., Heat shock protein expression in vulnerable cells of the rat hippocampus as an indicator of excitation-induced neuronal stress, J. Neurosci., 12 (1992) 3004-3009.
47. [47] Sperk, G., Marksteiner, J., Gruber, B., Bellmann, R., Mahata, M. and Ortler, M., Functional changes in neuropeptide Y and somatostatin containing neurons induced by limbic seizures in the rat. Neuroscience, 50 (1992) 831-846.
48. [48] Sperk, G., Kainic acid seizures in the rat, Prog. Neurobiol., 42 (1994) 1-32.
49. [49] Sternberger, L., Immunohistochemistry, 2nd ed., Wiley, New York, 1979.
50. [50] Stringer, J. and Lothman, E.W., Bilateral maximal dentate activation is critical for the appearance of an after-discharge in the dentate gyrus, Neuroscience, 46 (1992) 309-314.
51. [51] Tavianini, M.A., Hayes, T.E., Magazin, M.D., Minth, C.D. and Dixon, J.E., Isolation, characterization, and DNA sequence of the rat somatostatin gene, J. biol. Chem., 259 (1984) 11798-11803.
52. [52] Vezzani, A., Serafini, R., Stasi, M.A., Vigano', G., Rizzi, M. and Samanin, R., Somatostatin and its octapeptide analog SMS 201-995 modulate seizures induced by quinolinic and kainic acids differently in the rat hippocampus, Neuropharmacology, 30 (1991) 345-352.
53. [53] Vezzani, A., Monno, A., Rizzi, M., Galli, A., Barrios, M. and Samanin, R., Somatostatin release is enhanced in the hippocampus of partially and fully kindled rats, Neuroscience, 51 (1992) 41-46.
54. [54] Vezzani, A., Civenni, G., Rizzi, M., Monno, A., Messali, S. and Samanin, R., Enhanced neuropeptide Y release in the hippocampus is associated with chronic seizure susceptibility in kainic acid treated rats, Brain Res., 660 (1994) 138-143.
55. [55] Wanscher, B., Kragh, J., Barry, D.I., Bolwig, T. and Zimmer, J., Increased somatostatin and enkephalin-like immunoreactivity in the rat hippocampus following hippocampal kindling, Neurosci. Lett., 118 (1990) 33-36.
56. [56] Ylinen, A., Valjakka, A., Lahtinen, H., Miettinen, R., Freund, T.F. and Riekkinen, P., Vigabatrin pre-treatment prevents hilar somatostatin cell loss and the development of interictal spiking activity following sustained stimulation of the perforant path, Neuropeptides, 19 (1991) 205-211.
57. [57] Young, W.S. III, In situ hybridization. Histochemical detection of neuropeptide mRNA using DNA and RNA probes, Methods Enzymol., 168 (1989) 702-709.